Aquestive Therapeutics Amends Bylaws to Simplify Governance
Aquestive Therapeutics has updated its bylaws, altering stockholder nomination processes to enhance governance flexibility.
Kearny Financial Corp. Schedules Annual Meeting Investor Presentation
Kearny Financial Corp. announces an investor presentation for its fiscal 2026 Annual Meeting of Stockholders, emphasizing transparency and engagement.
Huntington Ingalls Industries appoints C. Michael Petters to Board
Huntington Ingalls Industries has appointed C. Michael Petters to its Board of Directors, enhancing leadership in the shipbuilding sector.
Integra LifeSciences secures $1.65 billion credit facility
Integra LifeSciences Holdings Corp announces a $1.65 billion credit facility and a $450 million bond offering to enhance liquidity and financial stability.
Vail Resorts amends credit agreement, alters control definition
Vail Resorts, Inc. has amended its credit agreement, changing the definition of a Change of Control Transaction, potentially impacting the amusement and recreation industry.
ACV Auctions completes merger with Copart, Inc.
ACV Auctions Inc. announces the completion of its merger with Copart, Inc., marking a pivotal change in its corporate structure and industry positioning.
CBRE Group announces acquisition of Onnec Group Limited
CBRE Group, Inc. has entered into a definitive agreement to acquire Onnec Group Limited, enhancing its data center infrastructure services.
Surrozen reports financial results after successful second closing
Surrozen, Inc. announces financial results following its second closing under a securities purchase agreement, marking a significant milestone for the company.
West Coast Community Bancorp Declares Quarterly Cash Dividend
West Coast Community Bancorp announces a $0.29 quarterly cash dividend, marking a $0.04 increase from the previous dividend, reflecting financial stability.
United Therapeutics announces $2 billion share repurchase plan
United Therapeutics Corp has authorized a $2 billion share repurchase program, reflecting confidence in its financial strength and commitment to shareholders.
Southern First Bancshares Reports Strong Q3 2026 Results
Southern First Bancshares announced a 41% increase in net income for Q3 2026, highlighting strong loan growth and margin expansion.
Federal Home Loan Bank of Des Moines Names New Chief Business Officer
Brett L.A. Manning appointed as Chief Business Officer of Federal Home Loan Bank of Des Moines, effective immediately.
LanzaTech Global completes recapitalization to boost LanzaJet
LanzaTech Global, Inc. has completed a recapitalization and deleveraging transaction to support LanzaJet's growth in sustainable aviation fuel.
Alaska Air Group reports Q3 2026 results, reveals losses
Alaska Air Group announces Q3 2026 results, showing a net loss of $147 million while expanding its international network and focusing on premium revenue growth.
Apollo Debt Solutions BDC announces unregistered share sale
Apollo Debt Solutions BDC has sold unregistered Class I common shares and declared distributions for its shareholders, raising over $11 million.
Netcapital Inc. Secures Financing Through Promissory Note
Netcapital Inc. has closed a financing deal with Hinterland Partners, issuing a promissory note of up to $641,936.66 to strengthen its financial position.
Treasure Global Inc acquires budget hotel business in Malaysia
Treasure Global Inc has finalized an agreement to acquire a budget hotel business in Malaysia for RM2.4 million, expanding its portfolio in the business services sector.
NexMetals Mining updates Mineral Resource Estimate for Selebi
NexMetals Mining Corp. announces an updated Mineral Resource Estimate for Selebi North, reflecting potential growth in its mining assets.
Vertex Pharmaceuticals Appoints Daniel Brennan to Board
Vertex Pharmaceuticals has appointed Daniel Brennan to its board, expanding its leadership team as it navigates the pharmaceutical industry.
Curanex Pharmaceuticals faces class action lawsuits over IPO
Curanex Pharmaceuticals Inc is facing class action lawsuits alleging misstatements in its IPO documents, raising concerns in the pharmaceutical industry.